Authors' objectives: The sacroiliac joint (SIJ) has been implicated as the primary source of pain in 10% to 30% of patients with chronic low back pain. SIJ dysfunction is characterized by the malalignment or abnormal movement of the SIJ. Description of Technology: The iFuse Implant System was developed for minimally invasive SIJ fusion in patients who have not experienced adequate relief from nonsurgical management. The iFuse system consists of sterile, rigid titanium rods that are designed to minimize joint rotation, maximize joint surface area, and facilitate biologic fixation to bone. Using general anesthesia, fluoroscopic guidance, and a small incision, an orthopedic or neurologic surgeon places a series of 2 to 4 implants (typically 3) across the SIJ. No bone grafting is required. Patient Population: The iFuse Implant System is indicated for use in patients with SIJ dysfunction that is a direct result of SIJ disruption and degenerative sacroiliitis. Clinical Alternatives: Alternatives to SIJ fusion using minimally invasive surgery with iFuse implants include nonsurgical methods such as physical therapy, medications (including anti-inflammatory agents), pelvic/sacroiliac belts, chiropractic management, intra-articular or periarticular steroid or anesthesia injections, or radiofrequency ablation of the lateral branches of the sacral nerve roots (neurotomy). Alternative surgical methods include open or minimally invasive SIJ fusion employing devices other than iFuse implants.

Project Status: Completed

Year Published: 2016

URL for published report: The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=16345

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: United States

Organisation Name: HAYES, Inc.

Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218

Contact Name: saleinfo@hayesinc.com

Contact Email: saleinfo@hayesinc.com

Copyright: Winifred S. Hayes, Inc